Silencing of UBE2D1 inhibited cell migration in gastric cancer, decreasing ubiquitination of SMAD4

Abstract Background Gastric cancer (GC) is the second leading cause of cancer-related deaths. Because it is hard to diagnose at early stage, the overall 5 years survival rate is lower than 25%. High migration is the main hallmark of malignant cells at advanced stage of GC. Thus, it is urgent to find...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Honghu Xie, Yu He, Yugang Wu, Qicheng Lu
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
EMT
GC
Acceso en línea:https://doaj.org/article/5d5007ca026846e5bb4d44006a7cc1f8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5d5007ca026846e5bb4d44006a7cc1f8
record_format dspace
spelling oai:doaj.org-article:5d5007ca026846e5bb4d44006a7cc1f82021-11-14T12:13:21ZSilencing of UBE2D1 inhibited cell migration in gastric cancer, decreasing ubiquitination of SMAD410.1186/s13027-021-00402-21750-9378https://doaj.org/article/5d5007ca026846e5bb4d44006a7cc1f82021-11-01T00:00:00Zhttps://doi.org/10.1186/s13027-021-00402-2https://doaj.org/toc/1750-9378Abstract Background Gastric cancer (GC) is the second leading cause of cancer-related deaths. Because it is hard to diagnose at early stage, the overall 5 years survival rate is lower than 25%. High migration is the main hallmark of malignant cells at advanced stage of GC. Thus, it is urgent to find biomarkers for early diagnosis and more effective therapy of GC. Methods In this study, lentivirus-mediated silencing and overexpression lentiviruses targeting the ubiquitin-conjugating enzyme E2 D1 (UBE2D1), transwell, wound healing, and pulmonary metastasis mouse model were applied to analyze the function of UBE2D1 in vitro and in vivo. Real-time PCR and immunohistochemistry were used to elucidate the level of UBE2D1 in GC samples. Results Silencing of UBE2D1 inhibited cell migration and the levels of epithelial-mesenchymal transition makers (MMP2 and MMP9) in AGS and MKN45 cells. Silencing of UBE2D1 inhibited cell metastasis in mouse model. On the contrary, UBE2D1 overexpression increased cell migration and the levels of MMP2 and MMP9 in MGC-803 cells. Further, silencing of UBE2D1 decreased the ubiquitination level of mothers against decapentaplegic homolog 4 (SMAD4), and the increase of cell migration induced by UBE2D1 overexpression could be reversed by SMAD4. Conclusion Silencing of UBE2D1 inhibited cell migration through transforming growth factor β (TGF-β)/SMAD4 signaling pathway in GC.Honghu XieYu HeYugang WuQicheng LuBMCarticleUBE2D1SMAD4EMTGCNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282Infectious and parasitic diseasesRC109-216ENInfectious Agents and Cancer, Vol 16, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic UBE2D1
SMAD4
EMT
GC
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Infectious and parasitic diseases
RC109-216
spellingShingle UBE2D1
SMAD4
EMT
GC
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Infectious and parasitic diseases
RC109-216
Honghu Xie
Yu He
Yugang Wu
Qicheng Lu
Silencing of UBE2D1 inhibited cell migration in gastric cancer, decreasing ubiquitination of SMAD4
description Abstract Background Gastric cancer (GC) is the second leading cause of cancer-related deaths. Because it is hard to diagnose at early stage, the overall 5 years survival rate is lower than 25%. High migration is the main hallmark of malignant cells at advanced stage of GC. Thus, it is urgent to find biomarkers for early diagnosis and more effective therapy of GC. Methods In this study, lentivirus-mediated silencing and overexpression lentiviruses targeting the ubiquitin-conjugating enzyme E2 D1 (UBE2D1), transwell, wound healing, and pulmonary metastasis mouse model were applied to analyze the function of UBE2D1 in vitro and in vivo. Real-time PCR and immunohistochemistry were used to elucidate the level of UBE2D1 in GC samples. Results Silencing of UBE2D1 inhibited cell migration and the levels of epithelial-mesenchymal transition makers (MMP2 and MMP9) in AGS and MKN45 cells. Silencing of UBE2D1 inhibited cell metastasis in mouse model. On the contrary, UBE2D1 overexpression increased cell migration and the levels of MMP2 and MMP9 in MGC-803 cells. Further, silencing of UBE2D1 decreased the ubiquitination level of mothers against decapentaplegic homolog 4 (SMAD4), and the increase of cell migration induced by UBE2D1 overexpression could be reversed by SMAD4. Conclusion Silencing of UBE2D1 inhibited cell migration through transforming growth factor β (TGF-β)/SMAD4 signaling pathway in GC.
format article
author Honghu Xie
Yu He
Yugang Wu
Qicheng Lu
author_facet Honghu Xie
Yu He
Yugang Wu
Qicheng Lu
author_sort Honghu Xie
title Silencing of UBE2D1 inhibited cell migration in gastric cancer, decreasing ubiquitination of SMAD4
title_short Silencing of UBE2D1 inhibited cell migration in gastric cancer, decreasing ubiquitination of SMAD4
title_full Silencing of UBE2D1 inhibited cell migration in gastric cancer, decreasing ubiquitination of SMAD4
title_fullStr Silencing of UBE2D1 inhibited cell migration in gastric cancer, decreasing ubiquitination of SMAD4
title_full_unstemmed Silencing of UBE2D1 inhibited cell migration in gastric cancer, decreasing ubiquitination of SMAD4
title_sort silencing of ube2d1 inhibited cell migration in gastric cancer, decreasing ubiquitination of smad4
publisher BMC
publishDate 2021
url https://doaj.org/article/5d5007ca026846e5bb4d44006a7cc1f8
work_keys_str_mv AT honghuxie silencingofube2d1inhibitedcellmigrationingastriccancerdecreasingubiquitinationofsmad4
AT yuhe silencingofube2d1inhibitedcellmigrationingastriccancerdecreasingubiquitinationofsmad4
AT yugangwu silencingofube2d1inhibitedcellmigrationingastriccancerdecreasingubiquitinationofsmad4
AT qichenglu silencingofube2d1inhibitedcellmigrationingastriccancerdecreasingubiquitinationofsmad4
_version_ 1718429347782590464